Odesa Regional Clinical Hospital

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Multiple sclerosis2 trials
• Coronary artery disease1 trial
• Crohn's disease1 trial
• Heart failure1 trial
• Ulcerative colitis1 trial

Phase

• Phase 33 trials
• Phase 42 trials

Status

• Completed3 trials
• Active, not recruiting2 trials

Lead sponsor

• Alimentiv Inc.2 trials
• Hoffmann-La Roche2 trials
• Boehringer Ingelheim1 trial

Running trials

• Active, not recruiting

  A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)

  NCT04586010· Phase 3· Hoffmann-La Roche· Source

• Active, not recruiting

  A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis

  NCT04544449· Phase 3· Hoffmann-La Roche· Source

Closed trials

• Completed

  EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)

  NCT04509674· Phase 3· Boehringer Ingelheim· Source

• Completed

  Determination of the Optimal Treatment Target in Ulcerative Colitis

  NCT04259138· Phase 4· Alimentiv Inc.· Source

• Completed

  Stopping Aminosalicylate Therapy in Inactive Crohn's Disease

  NCT03261206· Phase 4· Alimentiv Inc.· Source